These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32478627)

  • 1. Systemic lupus erythematosus and risk of infection.
    Barber MRW; Clarke AE
    Expert Rev Clin Immunol; 2020 May; 16(5):527-538. PubMed ID: 32478627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Lupus Erythematosus: A Review.
    Siegel CH; Sammaritano LR
    JAMA; 2024 May; 331(17):1480-1491. PubMed ID: 38587826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious complications in SLE after immunosuppressive therapies.
    Kang I; Park SH
    Curr Opin Rheumatol; 2003 Sep; 15(5):528-34. PubMed ID: 12960476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
    Fanouriakis A; Kostopoulou M; Andersen J; Aringer M; Arnaud L; Bae SC; Boletis J; Bruce IN; Cervera R; Doria A; Dörner T; Furie RA; Gladman DD; Houssiau FA; Inês LS; Jayne D; Kouloumas M; Kovács L; Mok CC; Morand EF; Moroni G; Mosca M; Mucke J; Mukhtyar CB; Nagy G; Navarra S; Parodis I; Pego-Reigosa JM; Petri M; Pons-Estel BA; Schneider M; Smolen JS; Svenungsson E; Tanaka Y; Tektonidou MG; Teng YO; Tincani A; Vital EM; van Vollenhoven RF; Wincup C; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2024 Jan; 83(1):15-29. PubMed ID: 37827694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus: review of synthetic drugs.
    Tsang-A-Sjoe MW; Bultink IE
    Expert Opin Pharmacother; 2015; 16(18):2793-806. PubMed ID: 26479437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilemma of immunosuppression and infection risk in systemic lupus erythematosus.
    He J; Li Z
    Rheumatology (Oxford); 2023 Mar; 62(Suppl 1):i22-i29. PubMed ID: 36987605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections in systemic lupus erythematosus.
    Navarra SV; Leynes MS
    Lupus; 2010 Oct; 19(12):1419-24. PubMed ID: 20947551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
    Mok CC; Tse SM; Chan KL; Ho LY
    Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
    Fanouriakis A; Kostopoulou M; Alunno A; Aringer M; Bajema I; Boletis JN; Cervera R; Doria A; Gordon C; Govoni M; Houssiau F; Jayne D; Kouloumas M; Kuhn A; Larsen JL; Lerstrøm K; Moroni G; Mosca M; Schneider M; Smolen JS; Svenungsson E; Tesar V; Tincani A; Troldborg A; van Vollenhoven R; Wenzel J; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2019 Jun; 78(6):736-745. PubMed ID: 30926722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
    Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
    Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.
    Danza A; Ruiz-Irastorza G
    Lupus; 2013 Oct; 22(12):1286-94. PubMed ID: 24098001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
    J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.
    Ugarte A; Danza A; Ruiz-Irastorza G
    Curr Opin Rheumatol; 2018 Sep; 30(5):482-489. PubMed ID: 29870497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus and infections.
    Singh BK; Singh S
    Reumatismo; 2020 Nov; 72(3):154-169. PubMed ID: 33213128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus: safe and effective management in primary care.
    Michalski JP; Kodner C
    Prim Care; 2010 Dec; 37(4):767-78, vii. PubMed ID: 21050957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.
    Thorbinson C; Oni L; Smith E; Midgley A; Beresford MW
    Paediatr Drugs; 2016 Jun; 18(3):181-95. PubMed ID: 26971103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.